WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 2063

Legislative bill overview

HB 2063 addresses opioid use disorder (OUD) treatment in Hawaii, though specific provisions are not detailed in the available information. Based on the referral to Health and Finance committees, the bill likely involves treatment access, funding mechanisms, or regulatory changes related to OUD care. The bill is in early legislative stages following its introduction on January 26, 2026.

Why is this important

Opioid use disorder remains a significant public health crisis affecting individuals, families, and healthcare systems. Hawaii, like many states, faces challenges with OUD treatment accessibility, medication-assisted treatment availability, and adequate funding for recovery services. Legislative action on OUD can expand treatment capacity, improve outcomes, and reduce overdose deaths and related social costs.

Potential points of contention

  • Treatment funding sources – Debates over whether the state should increase general fund appropriations, pursue federal grants, or establish new revenue mechanisms
  • Medication-assisted treatment (MAT) scope – Disagreement about which medications should be covered, prescriber qualifications, and accessibility standards
  • Insurance and coverage requirements – Tensions between mandating comprehensive OUD coverage and concerns about insurance cost increases

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.